| Market Closed - Euronext Paris 05:05:00 14/11/2026 HKT | ||
| 1.080 EUR | -0.92% |
|
| Current month | +8.00% | ||
| 1 month | +35.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Receive live all our recommendations
on Turbos and Warrants by Email or WhatsApp.
on Turbos and Warrants by Email or WhatsApp.
Chart
VIRBAC
Latest news about VIRBAC
| Date | Price | Change |
|---|---|---|
| 13/11/26 | €1.080 | -0.92% |
| 12/11/26 | €1.090 | -2.68% |
| 11/11/26 | €1.120 | 0.00% |
| 10/11/26 | €1.120 | -0.88% |
| 09/11/26 | €1.130 | +1.80% |
Static data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | VIRBAC |
| Issuer |
BNP Paribas
|
| HS3IB | |
| ISIN | FRBNPP04UNB2 |
| Date issued | 27/09/2022 |
| Strike | 250.63 € |
| Maturity | Unlimited |
| Parity | 100 : 1 |
| Emission price | 0.6700 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.795 € |
|---|---|
| Lowest since issue | 0.2550 € |
| Spread | 0.0800 € |
| Spread % | 7.14% |
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows:
- pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips;
- livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc.
Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Sector
-
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
354.50EUR
Average target price
412.29EUR
Spread / Average Target
+16.30%
- Stock Market
- Certificates
- HS3IB Certificat
Select your edition
All financial news and data tailored to specific country editions

BNP Paribas
















